Influenza Testing Market: By Test Type, Product, Type-of-Flu, End User, and Geography and forecast to 2030

Influenza Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test Type (Traditional Diagnostic Tests, Molecular Diagnostic Tests), Product (Point-Of-Care Testing, Immunodiagnostics, Molecular Diagnostics), Type-of-Flu (Type A Flu, Type B Flu, Type C Flu), End User (Hospitals/Clinical Laboratories, Reference Laboratories, Other End Users), and Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) and forecast to 2030

Influenza Testing Market was valued at US$ 2,673.3 million in 2023 and is expected to grow at an 6.1% CAGR from 2024 to 2030. Influenza is a communicable flu that is caused by a virus and spreads when people come in contact with the affected person. Influenza testing is generally done to check the main reason for the disease and proper diagnosis is being started to cure the patient. The growing incidence of influenza diseases due to the influenza virus and rising demand for rapid disease diagnosis are the significant factors responsible for driving the growth of the influenza testing market. For instance, in September 2022, National Influenza Centres and other laboratories from 102 countries tested over 112,017 specimens between 22nd August 2022 to 4th September 2022. Out of those, 3,879 tested positive for influenza viruses. Additionally, the increasing focus on quality of healthcare along with the growing concern of faster diagnosis and influenza control also heighten the overall growth of the influenza testing market.

However, factors such as the high cost included in influenza testing procedures obstruct the influenza testing market’s growth in the forecast period. On the other hand, the stringent regulatory framework has the potential to challenge the influenza testing market. Furthermore, the growth in influenza research for diagnostic technologies is expected to generate profitable opportunities for the influenza testing market. Moreover, the growing availability of point-of-care testing (POCT) in the area of rapid diagnostics of infectious diseases including flu, is expected to increase the demand for influenza testing in developing countries. For instance, a study was conducted in October 2022, to assess the POCT scope for infectious diseases in European countries. As per the study, under surveillance, POCT is widely used for infectious diseases with significant incidence rates, such as HIV and flu. Clinical research funding and expenditures in this field help to increase the scope of the projects that are done as well as the number of people engaged. Governments, the private sector, and businesses all provide money for research and development. For instance, in September 2019, the Collaboration Influenza Vaccine Innovations Centers (CIVICs) programme was launched by the National Institute of Allergy and Infectious Diseases (NIAID), a division of National Institutes of Health.

Recent Market Developments:

  • In August 2023, the U.S. FDA granted 510(k) clearance to a respiratory viral panel (RVP) developed by BD for the identification of patients with COVID-19, flue, and respiratory syncytial virus (RSV)
  • In February 2023, the U.S. FDA granted emergency use of authorization approval for Lucira COVID-19 & Flu Home Test developed by Pfizer Inc. to diagnose influenza viruses A and B. It is an over-the-counter (OTC) at-home diagnostic test.
  • In October 2022, Hologic Inc. launched its Aptima SARS-CoV-2/Flue test in Europe and North America. This approval is expected to drive market growth in both regions.

Influenza Testing Market Summary

Study Period

2024– 2030

Base Year

2023

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

Asia pacific

Influenza Testing Market Dynamics

Increasing healthcare expenditure and the availability of effective treatment options have led to an increase in the median age worldwide. The WHO, CDC, and European Centre for Disease Prevention and Control, among other regulatory bodies, are actively recording incidence & prevalence data to counter the disease systematically. These bodies work together with local governments to achieve overall control of the treatment and management of this disease. The Global Influenza Program (GIP) is one initiative the WHO undertook to provide technical support, strategic guidance, and coordination activities concerning zoonotic, pandemic, and seasonal flu cases. Such initiatives are expected to boost market growth during the forecast period.

Influenza Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024– 2030

Market Size in 2023

US$ 2,673.3 million

Market CAGR

6.1%

By Test Type

  • Traditional Diagnostics Tests
  • Molecular Diagnostics Tests

By Product

  • Point-Of-Care Testing
  • Immunodiagnostics
  • Molecular Diagnostics

By Type-of-Flu

  • Type A Flu
  • Type B Flu
  • Type C Flu

By End User

  • Hospitals
  • Clinical Laboratories
  • Reference Laboratories
  • Other End Users

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

Influenza Testing Market was valued at US$ 2,673.3 million in 2023 and is expected to grow at an 6.1% CAGR from 2024 to 2030.

3M Company, Abbott Laboratories, Becton, Dickinson and Company (BD), and Meridian Bioscience, Inc. are some of the major players operating in the influenza testing market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period.

North America accounts for the largest market share and is expected to be the primary market driver in the influenza testing market

High costs included in influenza testing procedures and stringent regulatory framework are expected to limit the growth of the influenza testing market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Influenza Testing Market Introduction 
2.1.Global Influenza Testing Market  - Taxonomy
2.2.Global Influenza Testing Market  - Definitions
2.2.1.Test Type
2.2.2. Product
2.2.3.Type-of-Flu
2.2.4.End Users
2.2.5.Region
3. Global Influenza Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Influenza Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Influenza Testing Market  By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Traditional Diagnostics Tests
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Molecular Diagnostics Tests
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Influenza Testing Market  By  Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Point-Of-Care Testing
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Immunodiagnostics
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Molecular Diagnostics
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Influenza Testing Market  By Type-of-Flu, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Type A Flu
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Type B Flu
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Type C Flu
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Influenza Testing Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Clinical Laboratories
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Reference Laboratories
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Other End Users
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Influenza Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Traditional Diagnostics Tests
10.1.2.Molecular Diagnostics Tests
10.2.   Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Point-Of-Care Testing
10.2.2.Immunodiagnostics
10.2.3.Molecular Diagnostics
10.3.  Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Type A Flu
10.3.2.Type B Flu
10.3.3.Type C Flu
10.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Clinical Laboratories
10.4.3.Reference Laboratories
10.4.4.Other End Users
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Influenza Testing Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Traditional Diagnostics Tests
11.1.2.Molecular Diagnostics Tests
11.2.   Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Point-Of-Care Testing
11.2.2.Immunodiagnostics
11.2.3.Molecular Diagnostics
11.3.  Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Type A Flu
11.3.2.Type B Flu
11.3.3.Type C Flu
11.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Clinical Laboratories
11.4.3.Reference Laboratories
11.4.4.Other End Users
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Traditional Diagnostics Tests
12.1.2.Molecular Diagnostics Tests
12.2.   Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Point-Of-Care Testing
12.2.2.Immunodiagnostics
12.2.3.Molecular Diagnostics
12.3.  Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Type A Flu
12.3.2.Type B Flu
12.3.3.Type C Flu
12.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Clinical Laboratories
12.4.3.Reference Laboratories
12.4.4.Other End Users
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Traditional Diagnostics Tests
13.1.2.Molecular Diagnostics Tests
13.2.   Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Point-Of-Care Testing
13.2.2.Immunodiagnostics
13.2.3.Molecular Diagnostics
13.3.  Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Type A Flu
13.3.2.Type B Flu
13.3.3.Type C Flu
13.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Clinical Laboratories
13.4.3.Reference Laboratories
13.4.4.Other End Users
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Traditional Diagnostics Tests
14.1.2.Molecular Diagnostics Tests
14.2.   Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Point-Of-Care Testing
14.2.2.Immunodiagnostics
14.2.3.Molecular Diagnostics
14.3.  Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Type A Flu
14.3.2.Type B Flu
14.3.3.Type C Flu
14.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Clinical Laboratories
14.4.3.Reference Laboratories
14.4.4.Other End Users
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.3M Company
15.2.2.Abbott Laboratories
15.2.3.Becton, Dickinson and Company (BD)
15.2.4.Meridian Bioscience, Inc.
15.2.5.Quidel Corporation
15.2.6.Hoffmann-La Roche Ltd
15.2.7.SA Scientific Ltd
15.2.8.SEKISUI Diagnostics
15.2.9.Thermo Fisher Scientific, Inc.
15.2.10.Hologic, Inc.
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • 3M Company
  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Hoffmann-La Roche Ltd
  • SA Scientific Ltd
  • SEKISUI Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.

Related Industry Reports